Jurisdictions Expand MAT in Justice Settings During the Pandemic

Despite the challenges that COVID-19 poses for prisons and jails nationwide, Justice Community Opioid Innovation Network (JCOIN) partners have adopted innovative practices to address disruptions to treatment and expand medications for opioid use disorder (MOUD) access even amidst a pandemic. From expedited medicationaccess to the use of telehealth, modifications nationwide are helping to improve services and remove barriers for substance use disorder (SUD) treatment.

“COVID has surprisingly become a catalyst for long-overdue treatment improvements in justice settings and within the general population,” shared Faye Taxman, Ph.D., University Professor at George Mason University. Read more

0 views0 comments

Recent Posts

See All

FDA Approves Higher Dosage of Naloxone

The Food and Drug Administration recently announced the approval of a higher dose of naloxone nasal spray to treat opioid overdose. The FDA previously approved 2 mg and 4 mg naloxone products and has